{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-23-000049","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2023-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.984249+00:00","generated_at":"2026-06-12T21:39:00.166334+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PetMed Express Q1 net sales $78.2M (+11.5% YoY); net loss $(0.9)M; declares $0.30 dividend","bullets":["Net sales $78.2M, up 11.5% YoY from $70.2M; net loss $(0.9)M ($0.04 diluted loss) vs net income $2.8M ($0.14 EPS) in prior year.","Adjusted EBITDA $3.3M, down 47% from $6.3M; new customers up 25% YoY (third consecutive quarter).","Board declared quarterly dividend $0.30/share, payable Aug 18, 2023 to holders of record Aug 14, 2023.","Acquisition of PetCareRx closed Apr 3, 2023; contributed almost full quarter of consolidated results."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-23-000049","json":"https://secwatch.observer/filing/0001040130-23-000049.json","markdown":"https://secwatch.observer/filing/0001040130-23-000049.md","text":"https://secwatch.observer/filing/0001040130-23-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/0001040130-23-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/pets-20230731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:39:00.166334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"44f6a49e004f9c4d5c54bdae13513352debe50ed","claim":"PETMED EXPRESS INC reported first quarter ended June 30, 2023 results: revenue $78.2 million, net income Net loss for the quarter ended June 30, 2023 was $(0.9) million, EPS $(0.04) per diluted share.","evidence_excerpt":"Health Expert TM , today announced its financial results for its first quarter ended June 30, 2023. Quarterly Highlights • Net sales for the quarter ended June 30, 2023, were $78.2 million, compared to $70.2 million for the first quarter in the prior year, an increase of 11.5%. • PetMeds reported an increase in new customers of 25% year over year for the quarter","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/0001040130-23-000049-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended June 30, 2023"},{"label":"Revenue","value":"$78.2 million"},{"label":"Net income","value":"Net loss for the quarter ended June 30, 2023 was $(0.9) million"},{"label":"EPS","value":"$(0.04) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}